Financhill
Back

Castle Biosciences Quote, Financials, Valuation and Earnings

Castle Biosciences Price Quote

$24.28
-0.05 (6.03%)
(Updated: May 4, 2024 at 6:14 AM ET)

Castle Biosciences Key Stats

Buy
85
Castle Biosciences (CSTL) is a Buy

Day range:
$22.78 - $25.91
52-week range:
$9.26 - $26.70
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.62
P/B ratio:
1.67%

Volume:
839.8K
Avg. volume:
195.1K
1-year change:
6.2%
Market cap:
$671.7M
Revenue:
$219.8M
EPS:
$-1.14

How Much Does Castle Biosciences Make?

Is Castle Biosciences Growing As A Company?

  • What Is Castle Biosciences's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.74%
  • What Is Castle Biosciences's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Castle Biosciences Stock Price Performance

What Is Castle Biosciences 52-Week High & Low?

Castle Biosciences Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Castle Biosciences?

  • How Much Debt Does Castle Biosciences Have?
    Total long term debt quarterly is $10M
  • How Much Cash Does Castle Biosciences Have?
    Cash and short term investments quarterly total is $239.2M
  • What Is Castle Biosciences’s Book Value Per Share?
    Book value per share is 14.59

Is Castle Biosciences Cash Flow Positive?

  • What Is CSTL Cash Flow From Operations?
    Cash flow from operations (TTM) is $13M
  • What Is Castle Biosciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $7.6M
  • What Is Castle Biosciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$52.5M

Castle Biosciences Return On Invested Capital

  • Is Management Doing A Good Job?
    CSTL return on invested capital is -7.88%
  • What Is Castle Biosciences Return On Assets?
    ROA measures how assets are converting to revenues and is -7%
  • What Is CSTL Return On Equity?
    ROE is a measure of profitability and is -7.92%

Castle Biosciences Earnings Date & Stock Price

Castle Biosciences Competitors

Castle Biosciences Dividend Yield

Data Unavailable

Castle Biosciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 71.2%
Revenue: 73.6% 9.83%

Analyst Recommendations

Buy Recommendations: 8
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 33.50
Upside from Last Price: 37.69%

Major Shareholders

  • How many CSTL shares are owned by institutional investors?
    34.5M CSTL shares are owned by institutional investors
  • How many CSTL shares are owned by insiders?
    566.9K CSTL shares are owned by insiders